Upgrade to SI Premium - Free Trial

Evercore ISI on Humana (HUM): CenterWell partnership with Cuban Cost Plus offers 'some modest benefit'

April 27, 2026 9:14 AM
Evercore ISI analyst Elizabeth Anderson reiterated an In Line rating and $195.00 price target on Humana (NYSE: HUM)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments